EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

SCN8A self ‐limited infantile epilepsy: Does epilepsy resolve?

Emma Young iD, Rebekah Harris iD, Nico Lieffering iD, Guillem de Valles-Ibáñez iD, Denis Nyaga iD, Mark F Bennett iD, Michael S Hildebrand iD, Ingrid E Scheffer iD, Lynette G Sadleir iD

Epilepsia · 2024

DOI: 10.1111/epi.18016 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Epilepsia, 2024. Verfasst von Emma Young und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatrics and Child Health, University of Otago, Wellington, New Zealand. Hauptthemen laut MEDLINE: Epilepsy, NAV1.6 Voltage-Gated Sodium Channel. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Health and Medical Research Council, Health Research Council of New Zealand, Australian Medical Research Future Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

SCN8A variants cause a spectrum of epilepsy phenotypes ranging from self‐limited infantile epilepsy (SeLIE) to developmental and epileptic encephalopathy. SeLIE is an infantile onset focal epilepsy, occurring in developmentally normal infants, which often resolves by 3 years. Our aim was to ascertain when epilepsy resolves in SCN8A ‐SeLIE. We identified unpublished individuals with SCN8A ‐SeLIE and performed detailed phenotyping. Literature was searched for published SCN8A ‐SeLIE cases. Nine unpublished individuals from four families were identified (age at study = 3.5–66 years). Six had their last seizure after 3 years (range = 4–21 years); although drug‐responsive and despite multiple weaning attempts (1–5), five of six remain on antiseizure medications (carbamazepine, n = 3; lamotrigine, n = 2). We identified 29 published individuals with SCN8A ‐SeLIE who had data on seizure progression. Of the 22 individuals aged at least 10 years, reported here or in the literature, nine of 22 (41%) had seizure offset prior to 3 years, five of 22 (23%) had seizure offset between 3 and 10 years, and eight of 22 (36%) had seizures after 10 years. Our data highlight that more than half of individuals with SCN8A‐ SeLIE continue to have seizures into late childhood. In contrast to SeLIE due to other etiologies, many individuals have a more persistent, albeit drug‐responsive, form of epilepsy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EpilepsyNAV1.6 Voltage-Gated Sodium ChannelAdolescentAdultAgedChildChild, PreschoolFemaleHumansMaleMiddle AgedYoung AdultAnticonvulsants

Stichwörter der Autor:innen

SCN8ASeLIEfocal epilepsygenetic epilepsyseizure outcome

Substanzen

AnticonvulsantsNAV1.6 Voltage-Gated Sodium ChannelSCN8A protein, human

Autor:innen und Institutionen

  • Department of Paediatrics and Child Health, University of Otago, Wellington, New Zealand.
  • Epilepsy Research Centre, Department of Medicine, University of Melbourne, Austin Health, Heidelberg, Victoria, Australia.
  • Population Health and Immunity Division, Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.
  • Department of Medical Biology, University of Melbourne, Parkville, Victoria, Australia.
  • Neuroscience Research Group, Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, Victoria, Australia.
  • Department of Paediatrics, Royal Children's Hospital, University of Melbourne, Parkville, Victoria, Australia.

ORCID-Profile: Emma Young, Rebekah Harris, Nico Lieffering, Guillem de Valles-Ibáñez, Denis Nyaga, Mark F Bennett, Michael S Hildebrand, Ingrid E Scheffer, Lynette G Sadleir

Förderung

  • National Health and Medical Research Council
  • Health Research Council of New Zealand
  • Australian Medical Research Future Fund
  • Estate of Ernest Hyam Davis and the Tedd and Mollie Carr Endowment Trust
  • Cure Kids New Zealand
  • Freemasons New Zealand

Zitieren

APA

Young, E., Harris, R., Lieffering, N., de Valles-Ibáñez, G., Nyaga, D., Bennett, M. F., Hildebrand, M. S., Scheffer, I. E., & Sadleir, L. G. (2024). SCN8A self ‐limited infantile epilepsy: Does epilepsy resolve?. Epilepsia. https://doi.org/10.1111/epi.18016

Vancouver

Young E, Harris R, Lieffering N, de Valles-Ibáñez G, Nyaga D, Bennett MF, et al. SCN8A self ‐limited infantile epilepsy: Does epilepsy resolve?. Epilepsia. 2024. doi:10.1111/epi.18016

BibTeX
@article{Young2024,
  author = {Young, Emma and Harris, Rebekah and Lieffering, Nico and de Valles-Ibáñez, Guillem and Nyaga, Denis and Bennett, Mark F and Hildebrand, Michael S and Scheffer, Ingrid E and Sadleir, Lynette G},
  title = {SCN8A self ‐limited infantile epilepsy: Does epilepsy resolve?},
  journal = {Epilepsia},
  year = {2024},
  doi = {10.1111/epi.18016}
}
Kostenlos starten →